Przejdź do zawartości
Merck

Przejdź do

PP102

IgG2a Antibody, Mouse

2.2 mg/mL, Chemicon®

Zaloguj się, aby wyświetlić ceny organizacyjne i kontraktowe.

Wybierz wielkość

Zmień widok
Gabaryty przesyłkiSKUDostępnośćCena netto
1 mg

Przewidywany termin wysyłki18 maja 2026zKuehne + Nagel Sp. z o.o.

874,00 zł

Informacje o tej pozycji

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Clone:
monoclonal
Technique(s):
ELISA: suitable
Application:
ELISA
Citations:
11

874,00 zł


Przewidywany termin wysyłki18 maja 2026Szczegóły


Zamów zamówienie zbiorcze
Pomoc techniczna
Potrzebujesz pomocy? Nasz zespół doświadczonych naukowców chętnie Ci pomoże.
Pozwól nam pomóc


biological source

mouse

Quality Level

antibody form

purified immunoglobulin

clone

monoclonal

manufacturer/tradename

Chemicon®

concentration

2.2 mg/mL

technique(s)

ELISA: suitable

shipped in

dry ice

target post-translational modification

unmodified

General description

Purity: 95% or greater

Application

Mouse IgG2a Monoclonal Antibody control validated for use in ELISA.
Research Category
Inflammation & Immunology
Research Sub Category
Immunoglobulins & Immunology

Physical form

Format: Purified
Purified immunoglobulin. Liquid containing no preservatives.

Preparation Note

Maintain at -20°C in undiluted aliquots for up to 12 months. Do not thaw and refreeze.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Ta strona może zawierać tekst przetłumaczony maszynowo.

Porównaj podobne pozycje

Wyświetl pełne porównanie

Pokaż różnice

1 of 1

Ta pozycja
SAB5600001SAB4200783SAB5600004
clone

monoclonal

clone

RM219, monoclonal, recombinant monoclonal

clone

HP-6014, monoclonal

clone

RM223, monoclonal, recombinant monoclonal

biological source

mouse

biological source

-

biological source

mouse

biological source

-

antibody form

purified immunoglobulin

antibody form

purified immunoglobulin

antibody form

purified from hybridoma cell culture

antibody form

purified immunoglobulin

technique(s)

ELISA: suitable

technique(s)

ELISA: 0.005-0.2  μg/mL, immunoblotting: 0.5-2 μg/mL (non-reduced only), immunocytochemistry: 0.5-2 μg/mL, immunohistochemistry: 0.5-2 μg/mL

technique(s)

immunofluorescence: suitable, indirect ELISA: 0.07-0.15 μg/mL using 1 μg/mL Human IgG2 myeloma for coating

technique(s)

ELISA: 0.01 μg/mL, immunoblotting: 0.5-2 μg/mL (non-reduced only), immunocytochemistry: 0.5-2 μg/mL, immunohistochemistry: 0.5-2 μg/mL

shipped in

dry ice

shipped in

wet ice

shipped in

dry ice

shipped in

wet ice

Quality Level

100

Quality Level

100

Quality Level

-

Quality Level

100


Klasa składowania

12 - Non Combustible Liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable



Certyfikaty analizy (CoA)

Poszukaj Certyfikaty analizy (CoA), wpisując numer partii/serii produktów. Numery serii i partii można znaleźć na etykiecie produktu po słowach „seria” lub „partia”.

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów



Aberrant activation of the interleukin-2 autocrine loop through the nuclear factor of activated T cells by nonleukemogenic human T-cell leukemia virus type 2 but not by leukemogenic type 1 virus.
Niinuma, A; Higuchi, M; Takahashi, M; Oie, M; Tanaka, Y; Gejyo, F; Tanaka, N; Sugamura et al.
Journal of virology null
Richard H Weisbart et al.
Molecular immunology, 39(13), 783-789 (2003-03-06)
Methods for cell type specific targeted intracellular delivery of proteins in vivo remain limited. A murine monoclonal anti-dsDNA antibody, mAb 3E10, was selectively transported into skeletal muscle cells in vivo. The antibody bound a 200 kDa protein only found in
Martin Bentler et al.
Molecular therapy. Methods & clinical development, 30, 576-592 (2023-09-11)
De novo immune responses are considered major challenges in gene therapy. With the aim to lower innate immune responses directly in cells targeted by adeno-associated virus (AAV) vectors, we equipped the vector capsid with a peptide known to interfere with



Numer pozycji handlu globalnego

SKUNUMER GTIN
PP10204053252502972

Questions

Reviews

No rating value

Active Filters